FDA public hearing: Microbiology Medical Devices Panel for Sepsis November 10, 2016 Washington, DC. This was an open hearing on how recent regulatory changes affect the application of host response sepsis diagnostics for the clinical management of Antibiotics. Attended by the FDA Molecular Diagnostics Advisory Board IXP Staff in Attendance: Leo McHugh, Roy Davis

Read More